| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2013) |
Margarita Pondal [Canada] ; Connie Marras [Canada] ; Janis Miyasaki [Canada] ; Elena Moro [Canada] ; Melissa J. Armstrong [Canada] ; Antonio P. Strafella [Canada] ; Binit B. Shah [Canada] ; Susan Fox [Canada] ; L K Prashanth [Canada] ; Nicolas Phielipp [Canada] ; Anthony E. Lang [Canada] | Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic |
| 000039 (2012) |
Andreas R. Kupsch [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Frederick Weiland [États-Unis] ; Antonio Tartaglione [Italie] ; Susanne Klutmann [Allemagne] ; Melanie Buitendyk [Canada] ; Paul Sherwin [États-Unis] ; Ann Tate [États-Unis] ; Igor D. Grachev [États-Unis] | Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study |
| 000115 (2011) |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
| 000133 (2011) |
Brian Jeynes [Canada] ; John Provias [Canada] | The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease |
| 000136 (2011) |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
| 000137 (2011) |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
| 000139 (2011) |
Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis] | Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia |
| 000165 (2011) |
Jonathan Kimmelman [Canada] ; Katherine Duckworth [Canada] ; Tim Ramsay [Canada] ; Tiffini Voss [États-Unis] ; Bernard Ravina [États-Unis] ; Marina Elena Emborg [États-Unis] | Risk of surgical delivery to deep nuclei: A meta‐analysis |
| 000186 (2011) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 000292 (2011) |
Valerie Voon [Royaume-Uni] ; Mandy Sohr [Allemagne] ; Anthony E. Lang [Canada] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Jacqueline Whetteckey [États-Unis] ; Daniel Weintraub [États-Unis] ; Glen R. Wunderlich [Canada] ; Mark Stacy [États-Unis] | Impulse control disorders in parkinson disease: A multicenter case–control study |
| 000379 (2011) |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
| 000404 (2011) |
Valerie Cullen [États-Unis] ; S. Pablo Sardi [États-Unis] ; Juliana Ng [Canada] ; You-Hai Xu [États-Unis] ; Ying Sun [États-Unis] ; Julianna J. Tomlinson [Canada] ; Piotr Kolodziej [Canada] ; Ilana Kahn [États-Unis] ; Paul Saftig [Allemagne] ; John Woulfe [Canada] ; Jean-Christophe Rochet [États-Unis] ; Marcie A. Glicksman [États-Unis] ; Seng H. Cheng [États-Unis] ; Gregory A. Grabowski [États-Unis] ; Lamya S. Shihabuddin [États-Unis] ; Michael G. Schlossmacher [États-Unis, Canada] | Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing |
| 000464 (2010) |
Q J Almeida [Canada] ; C A Lebold [Canada] | Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment? |
| 000509 (2010) |
En Huang [Canada] ; Dianbo Qu [Canada] ; Yi Zhang [Canada] ; Katerina Venderova [Canada] ; M. Emdadul Haque [Canada] ; Maxime W. C. Rousseaux [Canada] ; Ruth S. Slack [Canada] ; John M. Woulfe [Canada] ; David S. Park [Canada] | The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death |
| 000515 (2010) |
Shen-Yang Lim [Canada, Malaisie] ; Anthony E. Lang [Canada] | The nonmotor symptoms of Parkinson's disease—An overview |
| 000563 (2010) |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease |
| 000655 (2010) |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
| 000665 (2010) |
Zhen Ni [Canada] ; Andrew D. Pinto [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Involvement of the cerebellothalamocortical pathway in Parkinson disease |
| 000674 (2010) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations |
| 000678 (2010) |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders |
| 000735 (2010) |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis] | Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis |
